World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR1883
Date of registration: 26/06/2009
Primary sponsor: Atrium Medisch Centrum Parkstad
Public title: Laxatives postoperative colorectal surgery.
Scientific title: Laxatives postoperative colorectal surgery. - LAPOCC
Date of first enrolment: 1/7/2009
Target sample size: 215
Recruitment status: recruiting
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1883
Study type:  intervention
Study design:  Randomised: Yes; Masking: Double; Control: Placebo; Group: Parallel; Type: 2 or more arms, randomized  
Countries of recruitment
The Netherlands
Contacts
Name: M.  Sosef
Address:  Atrium MC Heerlen Chirurgie, Postbus 4446 6401 CX Heerlen The Netherlands
Telephone: +31 45 576 66 66
Email: meindert.sosef@planet.nl
Affiliation: 
Name: R.L.G.M.  Blom
Address:  Postbus 4446, Atrium MC Heerlen afdeling chirurgie, Henri Dunantstraat 5 6401 CX Heerlen The Netherlands
Telephone: +31 (0)45-5766666
Email: r.blom@student.maastrichtuniversity.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients planned for elective colorectal surgery will be included regardless of age, underlying pathology or co-morbidity. Procedures to be performed include right hemicolectomy, transversectomy, left-hemicolectomy, sigmoid resection, low anterior resection, polypectomy, abdominoperineal resection, and laparoscopic right or left hemicolectomy.
Exclusion criteria: 1. Age <18 years;

2. Emergency procedures;

3. Contra-indications for the laxatives being used;

4. Lacking informed consent.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Postoperative ileus, Colorectal surgery, Colorectal pathology

Intervention(s)
The laxatives being used in this trial are magnesiumoxide and bisacodyl. Patients will receive the laxative or the placebo for three days postoperatively, twice daily starting on the evening of surgery.
Primary Outcome(s)
Time to gastrointestinal recovery, defined as time to first flatus or first defecation.
Secondary Outcome(s)
Appreciation of the laxatives being used, overall hospital stay and incidence of postoperative complications (anastomotic leakage, wound infection, intra-abdominal abscess).
Secondary ID(s)
NL28256.096.09
Source(s) of Monetary Support
Atrium Medisch Centrum Parkstad
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history